Credit Suisse analyst Sami Badri maintains UiPath (NYSE:PATH) with a Outperform and maintains $27.5 price target.
Franklin Covey Shares Fall After Q1 Results, Joins Theravance Biopharma, Voyager Therapeutics And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
U.S. stock futures were lower this morning, with the Dow Jones futures falling around 50 points on Friday.